| Product Name | mCRAMP, mouseGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ |
| Size | 1 mg |
| Catalog # | AS-61305 |
| US$ | $283 |
| Purity | % Peak Area By HPLC ≥ 95% |
This cathelicidin-related antimicrobial peptide (mCRAMP) is the sole murine cathelicidin. mCRAMP expression in the intestinal tract is restricted to surface epithelial cells in the colon. mCRAMP shows antimicrobial activity against the murine enteric pathogen Citrobacter rodentium and destroys skin Candida albicans. | |
| Detailed Information | |
| Storage | -20°C |
| References | Limura, M. et al. J. Immunol. 174, 4901 (2005); Lopez-Garcia, B. et al. J. Invest. Dermatol. 125, 108 (2005). |
| Molecular Weight | 3878.7 |
| GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ | |
| Sequence(Three-Letter Code) | H - Gly - Leu - Leu - Arg - Lys - Gly - Gly - Glu - Lys - Ile - Gly - Glu - Lys - Leu - Lys - Lys - Ile - Gly - Gln - Lys - Ile - Lys - Asn - Phe - Phe - Gln - Lys - Leu - Val - Pro - Gln - Pro - Glu - Gln - OH |
| Product Citations | Sakoulas, G. et al. (2014). Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus. J Mol Med 92, 139. Subramanian, H. et al. (2013). β-Defensins activate human mast cells via Mas-Related Gene X2. J Immunol 191, 345. doi:10.4049/jimmunol.1300023.Kulkarni, MM. et al. (2011). Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.Cell Microbiol 13, 913. doi: 10.1111/j.1462-5822.2011.01589.x.Gregorio, J. et al. (2010). Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J Exp Med 207, 2921.Gable, JE. et al. (2009). Fluorescence and UV resonance Raman study of peptide−vVesicle interactions of human cCathelicidin LL-37 and its F6W and F17W mutants Biochem 48, 11264. doi: 10.1021/bi900996q.Schlamadinger, DE. et al. (2009). Toxins and antimicrobial peptides: interactions with membranes.SPIE Proceedings 7397 doi: 10.1117/12.827439.Gryllos, I. et al. (2008). Induction of group A Streptococcus virulence by a human antimicrobial peptide. PNAS 105, 16755. |
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
结合物垫在层析时荧光微球在T线前面凝集的现象怎么解决呢,结合物垫增加了吐温和糖的含量还是有这种现象的
至于安全性,这是一款被国家食品药品监督管理局(CFDA)批准的有证产品,而CFDA批准三类医疗器械都是十分严格严谨的,所以产品本身安全性肯定没问题啦,不过使用的安全性也跟医生注射技术有关。
最近想做小鼠微循环的检测,参照了DissectingtheEffectsofIschemiaandReperfusionontheCoronaryMicrocirculationinaRatModelofAcuteMyocardialInfarction这篇文献,想做荧光微球。但是不知道这个荧光微球具体该怎么用,要怎么处理,文献写的不详细,问了厂家也是不太清楚,希望有大神可以指点,提供详细些的实验步骤。多谢。
各位大侠,微球作为局部缓释药物,怎么储藏呢,微球不是散开的吗,怎么形成像凝胶状的呢
我最近用乳化交联法制备壳聚糖盐酸盐微球,药物是水不溶性(醋酸共晶体),将药物乙醇溶液加入到3%壳聚糖盐酸盐溶液中,混合均匀,加入到含2%span80的液体石蜡,油水比6:1,乳化半小时,加入1.5ml戊二醛,交联30min,离心,用石油醚,丙酮各洗两次,干燥,得微球。
但是我研磨微球,用乙醇溶解药物,超声3h,在紫外下根本检测不到药物,包封率就没法算,我测了药物在石油醚和丙酮中都有一定的溶解度,洗的时候溶剂层也有药物的颜色,是不是微球中的药物都被洗了出来?还是只是把游离的药物洗了出来?药物根本就没被包进去?但是药物在有机溶剂中都有一定的溶解度,我该怎么做?有大神愿意告知一二吗????
版主shitou0307留言:
因为你还没学会怎么提问

![]()
暂无品牌问答
